Immune Cell Dysfunction and Inflammation in End-stage Renal Disease

Overview

Journal Nat Rev Nephrol

Specialty Nephrology

Date 2013 Mar 20

PMID 23507826

Citations 278

Authors

Michiel G H Betjes

Affiliations

Soon will be listed here.

Abstract

Uraemia causes inflammation and reduces immune system function as evidenced by an increased risk of viral-associated cancers, increased susceptibility to infections and decreased vaccination responses in patients with end-stage renal disease (ESRD). The substantially increased risk of atherosclerosis in these patients is also probably related to uraemia-associated inflammation. Uraemia is associated with a reduction in the number and function of lymphoid cells, whereas numbers of myeloid cells in uraemic patients are normal or increased with increased production of inflammatory cytokines and reactive oxygen species. Similar to healthy elderly individuals, patients with ESRD have increased numbers of specific proinflammatory subsets of T cells and monocytes, suggesting the presence of premature immunological ageing in these patients. These cells might contribute to inflammation and destabilization of atherosclerotic plaques, and have, therefore, been identified as novel nonclassical cardiovascular risk factors. The cellular composition of the immune system does not normalize after successful kidney transplantation despite a rapid reduction in inflammation and oxidative stress. This finding suggests that premature ageing of the immune system in patients with ESRD might be related to a permanent skewing of the haematopoetic stem cell population towards myeloid-generating subsets, similar to that seen in healthy elderly individuals.

Citing Articles

LILRB3 genetic variation is associated with kidney transplant failure in African American recipients.

Sun Z, Yi Z, Wei C, Wang W, Ren T, Cravedi P Nat Med. 2025; .

PMID: 40065170 DOI: 10.1038/s41591-025-03568-z.

Autologous cord blood individualized supplements in autistic spectrum disorder: CORDUS study results.

Stancioiu F, Bogdan R, Ivanescu B, Dumitrescu R World J Clin Pediatr. 2025; 14(1):96643.

PMID: 40059901 PMC: 11686574. DOI: 10.5409/wjcp.v14.i1.96643.

Mortality associated with the COVID-19 pandemic in the Swiss dialysis population beyond SARS-CoV-2 infection.

Jaques D, Hoessly L, Guidotti R, Koller M, Ponte B, Ambuehl P Clin Kidney J. 2024; 17(12):sfae322.

PMID: 39664996 PMC: 11630737. DOI: 10.1093/ckj/sfae322.

Terbinafine in acrylic polymer for the treatment of onychomycosis in hemodialysis patients: a phase II clinical trial.

Bersano J, Cordeiro M, Sciani J, Tescarollo I, Marson F Front Med (Lausanne). 2024; 11:1417985.

PMID: 39659625 PMC: 11628268. DOI: 10.3389/fmed.2024.1417985.

Unique Pathological Findings of Polarized Calcium Oxalate Crystals in Spondylodiscitis of an ESRD Hemodialysis Patient: A Case Report.

Mehrasa P, Hadimaleki S, Shafiee N, Khalaji A Clin Case Rep. 2024; 12(12):e9709.

PMID: 39649492 PMC: 11624114. DOI: 10.1002/ccr3.9709.

References

Lewis S, Van Epps D . Neutrophil and monocyte alterations in chronic dialysis patients. Am J Kidney Dis. 1987; 9(5):381-95. DOI: 10.1016/s0272-6386(87)80141-5. View

Vacher-Coponat H, Brunet C, Lyonnet L, Bonnet E, Loundou A, Sampol J . Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients. Nephrol Dial Transplant. 2007; 23(4):1406-14. DOI: 10.1093/ndt/gfm596. View

Recio-Mayoral A, Banerjee D, Streather C, Kaski J . Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease--a cross-sectional study of predialysis, dialysis and kidney-transplantation patients. Atherosclerosis. 2011; 216(2):446-51. DOI: 10.1016/j.atherosclerosis.2011.02.017. View

Girndt M, Pietsch M, Kohler H . Tetanus immunization and its association to hepatitis B vaccination in patients with chronic renal failure. Am J Kidney Dis. 1995; 26(3):454-60. DOI: 10.1016/0272-6386(95)90491-3. View

Anding K, Gross P, Rost J, Allgaier D, Jacobs E . The influence of uraemia and haemodialysis on neutrophil phagocytosis and antimicrobial killing. Nephrol Dial Transplant. 2003; 18(10):2067-73. DOI: 10.1093/ndt/gfg330. View

Foley R, Parfrey P, Sarnak M . Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998; 32(5 Suppl 3):S112-9. DOI: 10.1053/ajkd.1998.v32.pm9820470. View

Charest A, GrandMaison A, McDougall J, Goldstein M . Evolution of naturally acquired hepatitis B immunity in the long-term hemodialysis population. Am J Kidney Dis. 2003; 42(6):1193-9. DOI: 10.1053/j.ajkd.2003.08.020. View

Fernandez-Fresnedo G, Ramos M, de Francisco A, Lopez-Hoyos M, Arias M . B lymphopenia in uremia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2. Nephrol Dial Transplant. 2000; 15(4):502-10. DOI: 10.1093/ndt/15.4.502. View

Steinman R, Idoyaga J . Features of the dendritic cell lineage. Immunol Rev. 2010; 234(1):5-17. DOI: 10.1111/j.0105-2896.2009.00888.x. View

10.

Pahl M, Gollapudi S, Sepassi L, Gollapudi P, Elahimehr R, Vaziri N . Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression. Nephrol Dial Transplant. 2009; 25(1):205-12. PMC: 2796898. DOI: 10.1093/ndt/gfp397. View

11.

McHeyzer-Williams L, McHeyzer-Williams M . Antigen-specific memory B cell development. Annu Rev Immunol. 2005; 23:487-513. DOI: 10.1146/annurev.immunol.23.021704.115732. View

12.

Betjes M, Huisman M, Weimar W, Litjens N . Expansion of cytolytic CD4+CD28- T cells in end-stage renal disease. Kidney Int. 2008; 74(6):760-7. DOI: 10.1038/ki.2008.301. View

13.

Yoon J, Pahl M, Vaziri N . Spontaneous leukocyte activation and oxygen-free radical generation in end-stage renal disease. Kidney Int. 2006; 71(2):167-72. DOI: 10.1038/sj.ki.5002019. View

14.

Beaman M, Michael J, MacLennan I, Adu D . T-cell-independent and T-cell-dependent antibody responses in patients with chronic renal failure. Nephrol Dial Transplant. 1989; 4(3):216-21. DOI: 10.1093/oxfordjournals.ndt.a091858. View

15.

Ulrich C, Heine G, Gerhart M, Kohler H, Girndt M . Proinflammatory CD14+CD16+ monocytes are associated with subclinical atherosclerosis in renal transplant patients. Am J Transplant. 2007; 8(1):103-10. DOI: 10.1111/j.1600-6143.2007.02035.x. View

16.

Thibaudin D, Alamartine E, Mariat C, Absi L, Berthoux F . Long-term kinetic of T-lymphocyte subsets in kidney-transplant recipients: influence of anti-T-cell antibodies and association with posttransplant malignancies. Transplantation. 2005; 80(10):1514-7. DOI: 10.1097/01.tp.0000181193.98026.3f. View

17.

Betjes M, Langerak A, van der Spek A, de Wit E, Litjens N . Premature aging of circulating T cells in patients with end-stage renal disease. Kidney Int. 2011; 80(2):208-17. DOI: 10.1038/ki.2011.110. View

18.

Vesosky B, Flaherty D, Rottinghaus E, Beamer G, Turner J . Age dependent increase in early resistance of mice to Mycobacterium tuberculosis is associated with an increase in CD8 T cells that are capable of antigen independent IFN-gamma production. Exp Gerontol. 2006; 41(11):1185-94. DOI: 10.1016/j.exger.2006.08.006. View

19.

Nace G, Evankovich J, Eid R, Tsung A . Dendritic cells and damage-associated molecular patterns: endogenous danger signals linking innate and adaptive immunity. J Innate Immun. 2011; 4(1):6-15. DOI: 10.1159/000334245. View

20.

Sportes C, Hakim F, Memon S, Zhang H, Chua K, Brown M . Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J Exp Med. 2008; 205(7):1701-14. PMC: 2442646. DOI: 10.1084/jem.20071681. View